After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
This intro covers Wash Sale Rule 61 Day Window Dividend ETF, detailing the 61-day period and its implications for replacements.
18,680 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Berkshire Hathaway slashed its Amazon holding by 77% in the fourth quarter, leaving a lean position and sparking rene...
A two-year income lookback in Medicare pricing can surprise retirees after asset sales. This report explains how the ...
Amazon is raising 25 billion in long term bonds to finance its AI and cloud expansion, as executives outline a roughl...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Strategy, the software firm formerly known as MicroStrategy, reported a $12.77 billion first-quarter loss as Bitcoin ...
Amazon unveils a $25 billion bond tranche to accelerate AWS growth and custom silicon, highlighting a silicon-first p...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
As housing markets shift, investors wonder if Opendoor can deliver a meaningful stock reaction by 2026. This guide br...
SpaceX raised $25 billion through a bond offering that received top ratings from credit agencies, yet the stock still...
Bill Gates is downshifting his Seattle-area estate footprint, listing a neighboring home and pruning parcels around X...
As AI reshapes cinema, the lord rings director peter argues AI is a tool, not a replacement for actors. This article ...